Skip to content
Screener

Sight Sciences, Inc. SGHT Q2 2025 earnings

Reported August 7, 2025 · After market close

Revenue$19.6MBeat by $1.8M
EPS-$0.23Beat by $0.02
Revenue estimate$17.7M
EPS estimate-$0.25

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$23.6M
EPS estimate-$0.13

Financials

Q2 2025

Income statement

See full
Revenue$19.6M-8.5%
Gross profit$16.6M-9.6%
Operating income-$11.7M+7.8%
Net income-$11.9M+3.1%
EPS (diluted)-$0.23+8.0%

Balance sheet

See full
Cash & equivalents$101.5M-14.1%
Total debt$40.6M+15.8%
Total equity$70.0M-31.1%
Total assets$122.0M-18.5%

Cash flow

See full
Operating cash flow-$7.5M+20.3%
CapEx$210.0K+163%
Free cash flow-$7.8M+18.8%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$220.25M-33.3%
Enterprise value$159.32M-35.5%
P/S2.9×-1.3×

Profitability

See full
Gross margin85.4%-0.4pp
Operating margin-63.8%-1.5pp
Net margin-64.2%-1.6pp
FCF margin-30.1%-7.7pp

Returns & leverage

See full
Return on equity-57.1%+24.2pp
Debt / equity0.6×+0.2×
Current ratio10×-1.0×

Segments

By segment

See full
Surgical Glaucoma$19.2M-5.0%
Dry Eye$333.0K-70.4%

FAQ

When did Sight Sciences, Inc. report Q2 2025 earnings?
Sight Sciences, Inc. (SGHT) reported Q2 2025 earnings on August 7, 2025 after market close.
What were Sight Sciences, Inc.'s Q2 2025 revenue and EPS?
Sight Sciences, Inc. reported revenue of $19.6M and eps of $-0.23 for Q2 2025.
Did Sight Sciences, Inc. beat estimates in Q2 2025?
Revenue beat the consensus estimate of $17.7M by $1.8M. EPS beat the consensus estimate of $-0.25 by $0.02.
How did Sight Sciences, Inc.'s Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 8.5% from $21.4M a year earlier and eps grew 8.0% from $-0.25.
Where can I find Sight Sciences, Inc.'s Q2 2025 SEC filings?
You can read the 8-K earnings release (0000950170-25-105012) and the 10-Q periodic report (0000950170-25-105065) directly on SEC EDGAR. The filing index links above go to sec.gov.